CBIO - Catalyst Biosciences Inc
Close
0.5113
-0.014 -2.719%
Share volume: 483,723
Last Updated: Mon 30 Oct 2023 09:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.53
-0.01
-2.65%
Fundamental analysis
27%
Profitability
8%
Dept financing
6%
Liquidity
72%
Performance
40%
Performance
5 Days
5.04%
1 Month
8.89%
3 Months
40.09%
6 Months
147.74%
1 Year
-9.57%
2 Year
-39.28%
Key data
Stock price
$0.51
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.19 - $0.74
52 WEEK CHANGE
-$0.10
DIVIDEND
$0.24
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Nassim Usman
Region: US
Website:
Employees: 35
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Region: US
Website:
Employees: 35
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Recent news